NuVasive (NUVA) Tops Q4 EPS by 9c

NuVasive (NASDAQ: NUVA) reported Q4 EPS of $0.73, $0.09 better than the analyst estimate of $0.64. Revenue for the quarter came in at $310.4 million versus the consensus estimate of $304.78 million.

For earnings history and earnings-related data on NuVasive (NUVA) click here.

You May Also Be Interested In

• L3Harris CEO steps down amid conduct review, shares drop
• Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c
• Vislink Technologies Inc. (VISL) Misses Q2 EPS by 7c